The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
Pericarditis market to reach $3.64 billion by 2030 at 7.9% cagr, driven by increasing prevalence of cardiovascular diseases.
Read More
Perfusion bioreactor with artificial intelligence control market to reach $4.85 billion by 2030 at 20.8% cagr, driven by increasing prevalence of personalized medicine.
Read More
Performance enhancing drugs market to reach $14.91 billion by 2030 at 5.4% cagr, driven by rising interest in fitness activities.
Read More
Peptide therapeutics contract active pharmaceutical ingredient manufacturing market to reach $4.11 billion by 2030 at 7.3% cagr, driven by rising prevalence of diabetes.
Read More
Peptide therapeutics market to reach $83.57 billion by 2030 at 11.2% cagr, driven by increase in prevalence of chronic diseases.
Read More
Peptide supplements market to reach $5.89 billion by 2030 at 10.2% cagr, driven by rising awareness of health and wellness.
Read More
Peptide drug conjugates market to reach $7.44 billion by 2030 at 15.3% cagr, driven by growing demand for personalized treatments.
Read More
Peptide based metabolic disorders therapeutics market to reach $63.7 billion by 2030 at 13.0% cagr, driven by rising prevalence of obesity.
Read More
Peptide antibiotics market to reach $9.04 billion by 2030 at 9.3% cagr, driven by increase in prevalence of infectious diseases.
Read More
Peptide and oligonucleotide cdmo market to reach $4.03 billion by 2030 at 10.5% cagr, driven by growing adoption of personalized medicine.
Read More